"If everyone is moving forward together,

then sucess takes care of itself"

Henry Ford


Octreotide acetate

The active ingredient Octreotide acetate is a synthetic Somatostatin-analogon


- For treatment of acromegaly

- For symptomatic treatment of endocrine tumors of the gastrointestinal tract

- For prophylaxis for postoperative pancreatic complications following pancreatic surgery

Pharmaceutical form and presentations

Solution for injection:

- 0,05 mg/ml in 1 ml ampoule

- 0,1 mg/ml in 1 ml ampoule

- 0,5 mg/ml in 1 ml ampule

- 0,2 mg/ml in 5 ml injection vial

Please note that this is not the slow release form, known as Octreotide LAR.


- Subcutaneous injection

Produced in

- European Union

Available countries

- On request


Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.